Document:

Exhibit 10
 	
            Transition Agreement between Bene Japan and Registrant
 

 

 

Transition Agreement Between Bene Co., Ltd and 

Bene IO, Inc.

 

Effective January 1, 2007

 

This Transition Agreement entered into as of January 1, 2007, between Bene Co., Ltd. (“BC”), a Japan corporation, and Bene IO, Inc. (“IO”), a Delaware corporation.

 

RECITALS

 

Whereas, the Board of Directors of Bene Co. and Bene IO have each determined that it would be appropriate and desirable for BC to contribute and transfer to IO, and for IO to receive and assume, directly or indirectly, substantially all of the assets of BC, but none of the liabilities associated with BC;

 

Whereas BC has acquired IO and caused IO to be re-incorporated in order to effect the transition;

 

Whereas BC seeks to become a public company and BC believes that being a public company with its HQ in the U.S. will facilitate sales;

 

Whereas IO is a U.S. public company;

 

Whereas the parties intend in this Agreement to set forth the principal arrangements between them regarding the transition of BC to IO;

 

Whereas in consideration of the receipt noted above, the major shareholders (see attached list) will receive stock certificates of IO which amounts to the percentage of ownership equaling 99%.

 

Now, therefore, in consideration of the foregoing, the parties hereto agree as follows:

 

ARTICLE I – TRANSITION

 

Section 1.1 Unless otherwise provided in this Agreement or in any agreement to be executed in connection with this Agreement, the effective time and date of each transfer of assets shall take place through out the year of 2007.

 

ARTICLE II – DOCUMENTS AN ITEMS TO BE DELIVERED IN 2007

 

Section 2.1 Documents to Be Delivered By BC.  During 2007, BC will deliver to IO any and all certificates representing any stock and /or investments, and any other assets that have certificates of ownership.

 

Section 2.2 Resignations of each person who is an officer or director of BC and their acceptance of employment with IO during the transition period in 2007.

 

Section 2.3 Any other agreements, documents or instruments as the parties may agree are necessary or desirable in order to achieve the purpose of the transfer.

 

ARTICLE III – REPRESENTATIONS OR WARRANTY

 

BC does not, in the agreement or any other agreement, instrument or document make any representation as to the value of any asset or thing of value to be transferred to IO or the freedom from encumbrance of any asset or thing of value to be transferred to IO.

 

ARTICLE IV – MISCELLANEOUS

 

In no event shall any member of the BC group or IO group be liable to any other member of the BC group or IO group for any special, consequential, indirect, incidental or punitive damages or lost profits, however caused and on any theory of liability (including negligence) arising in any way out of this agreement.

 

Section 4.2 Entire Agreement.  This Agreement and any other Ancillary Agreements constitutes the entire agreement between the parties.

 

Section 4.3 Governing Law.  This Agreement shall be governed and construed and enforced in accordance with the laws of the State of Delaware as to all matters regardless of the laws that might otherwise govern under the principles of conflicts of laws applicable thereto.

 

Section 4.4 Termination.  This Agreement and all Ancillary Agreements may be terminated and the Transfer of Assets abandoned at any time prior to the end of the transition phase.  In the event of termination pursuant to this Section, no party shall have any liability of any kind to the other party.

 

Section 4.5 Assignment.  This Agreement may not be assigned by any party hereto.

 

Section 4.6 Amendment.  No change or amendment will be made to this Agreement except by an instrument in writing signed on behalf of each of the parties to such agreement.

 

Section 4.7 Authority.  Each of the parties hereto represents to the other that it has the corporate or other requisite power and authority to execute, deliver and perform this Agreement and this Agreement is a legal, valid and binding obligation enforceable against it in accordance with its terms subject to applicable laws and general equity principles.

 

Date:  Jan. 18, 2007

 

/s/ Emiko Kuriyama, President

For Bene Co., Ltd. Signature and Title

 

/s/ Emiko Kuriyama, President

For Bene IO, Inc. Signature and TitleExhibit 10.2 Product Brochure in Japan

 

BENE IO

 

Our first objective is to provide a healthy daily life style.

 

Easy to take soft capsules

 

The soft football-shaped capsules are easy to take.

 

The letters, “BENE” are printed on each capsule verifying its originality.

 

PINE BENE IO

 

Aluminum Pack (90 pcs)

 

Suggested Retail Price 11,550 Yen

 

PINE BENE IO

 

Compact Case (30 pcs)

Suggested retail 4,200 yen

 

Name of Product

Pine Bene IO (An Extract from Pine Bark)

 

Type of Product 

Health Supplement

 

 

NAME OF INGREDIENTS

 

DHA (Docosahexaenoic Acid) – Refined fish oil

 

Safflower Oil

 

Blueberry Extract

 

Coenzyme Q10

 

Pine Bark Extract

 

Gelatin

 

Soy Lecithin

 

Glycerine

 

Vitamin E

 

Glycerine Fatty Acid Ester

 

Marigold Pigment

 

Vitamin C

 

Page 2 of brochure

 

RETAIL COST

 

Suggested retail cost

 

	
             
 	
            (a)
 	
            90 pcs, approx. 47.7 grams – 11,550 yen (including tax)
 

	
             
 	
            (b)
 	
            30 pcs, approx. 15.9 – 4,200 yen (including tax)
 

 

Repeat Order Pricing

	
             
 	
            (a)
 	
            90 pcs, approx. 47.7 grams – 9,450 yen (tax included)
 

 

DIRECTIONS FOR USAGE

 

For use as a supplement, the recommended dosage is three (3) capsules every day with water (warm or cold).  Swallow the capsules whole without chewing as the ingredients have a purplish color.

 

Warning:  If for any reason there is any reaction, please consult a physician.

 

RIGHT SIDE COLUMN

 

NUTRITIONAL FACTS

 

3 CAPSULES

 

	
            Calorie
 	
            9.9 kcal
 

 

	
            Protein
 	
            0.4 g
 

 

	
            Lipids
 	
            0.8 g
 

 

	
            Carbohydrates
 	
            0.3 g
 

 

	
            Sodium
 	
            0.4 mg
 

 

	
            Vitamin A (Retinal)
 	
            12.2 ug
 

 

	
            Vitamin E
 	
            46.6 mg
 

 

	
            Vitamin C
 	
            9.2 mg
 

 

(Analytic Examination by the Japan Food Analysis Center)

 

INGREDIENTS AND CONTENT

 

With 3 capsules

 

	
            Lutein
 	
            6.36 mg
 

 

	
            Zeaxanthin
 	
            0.27 mg
 

 

 

	
            Phospatidyl Choline
 	
            82.11 mg
 

 

	
            Docosahexaenoic Acid
 	
            100.05 mg
 

 

	
            Anthocyanin
 	
            28.35 mg
 

 

	
            Coenzyme Q10
 	
            30 mg
 

 

(Analytic Examination by the Japan Food Analysis Center)

 

	
            Seller:
 	
            Bene IO (Japan Office)
 

2-9-1 Akabane, Kita-ku, Tokyo  

 

(*Translator’s note: this is the company’s new Japan address; the old address is the one actually on the brochure.)

 

For manufacturing information: Korin Pharmaceutical

Toll Free: 0120-520-310Exhibit 10.2 Product Brochure in Japan

 

For a healthy brilliant, and shinny skin

 

KIRABI BENE IO

Kirabei Bene IO

 

One Bottle 720 ml

Suggested Retail Price 11,550 Yen

 

PRODUCT NAME

 

KIRABEI BENE IO

 

TYPE OF PRODUCT

 

Refreshing drink

 

INGREDIENTS

 

	
             
 	
            -
 	
            Malt Kernel syrup concentrate
 

	
             
 	
            -
 	
            Blueberry Fruit Juice Concentrate
 

	
             
 	
            -
 	
            Galatose oligosaccheride
 

	
             
 	
            -
 	
            Allonium Fruit Juice Concentrate
 

	
             
 	
            -
 	
            Cassis Extract
 

	
             
 	
            -
 	
            Grape Seed Extract
 

	
             
 	
            -
 	
            Lutein
 

	
             
 	
            -
 	
            Hydrouronic acid
 

	
             
 	
            -
 	
            L-theanine
 

	
             
 	
            -
 	
            Chrysanthemum Extract
 

	
             
 	
            -
 	
            Allorear
 

	
             
 	
            -
 	
            Flavorings
 

 

SUGGESTED RETAIL COST

 

Bottle (720)

Suggested retail 11,550 yen

 

Members Price: 9,450 Yen

 

DIRECTIONS FOR USAGE

 

After shaking each day using the cup provided with bottle, take 1 – 3 cupfuls.  (1 cup = approx. 25 ml)

 

If preferred, can be mixed with water or other drink.

 

NUTRITIONAL FACTS

 

1 bottle approx. 720 ml

 

	
            Calories
 	
            358.0 kcal
 

	
            Protein
 	
            6.9 g
 

	
            Lipids
 	
            0.8 g
 

	
            Carbohydrates
 	
            103.6 g
 

	
            Sodium
 	
            30.5 mg
 

 

(Analytic Examination provided by Japan Food Analysis Center)

 

Ingredients and Contents

 

1 Bottle approx. 720 ml

 

Blueberry Fruit Juice Concentrate 72,000

 

Allorear Fruit Juice Concentrate 5,184 mg

Cassis Extract 2,880 mg

 

Fermented Blueberry Peptide 20,016 mg

Hydrouronic Acid 50 mg

 

(Analytic Examination Provided by the Japan Food Analysis Center)

 

Seller: Bene IO

2-9-1 Akabane, Kita-ku

Tokyo, Japan

(* See translator’s note above)

 

For Manufacturing Information:

 

Korin Pharmaceuticals

Toll Free 0120-52-310

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00119-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00119-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00119-of-00352.parquet"}]]